Source: Reunion Neuroscience (formerly Field Trip Health)
  • Field Trip Health & Wellness (FTHW) has received approval from the Financial Regulatory Authority to start trading on the OTCQB Market in the US
  • The shares of Field Trip were expected to start trading on the OTCQB Market under the symbol “FTHWF” from February 2, 2023
  • The OTCQB is a U.S. trading platform operated by the OTC Markets Group and is the leading marketplace of early-stage and developing U.S. and international companies
  • Field Trip Health & Wellness Ltd. engages in the development and delivery of psychedelic therapies
  • Field Trip Health & Wellness Ltd. opened trading at C$0.105

Field Trip Health & Wellness (FTHW) has received approval to start trading on the OTCQB Market in the United States.

The company received approval from the Financial Regulatory Authority (FINRA) for its shares to commence trading on the OTCQB Market.

The shares of Field Trip were expected to start trading on the OTCQB Market under the symbol “FTHWF” from February 2, 2023.

Field Trip will continue to trade on the TSX Venture Exchange under its existing symbol, “FTHW.”

The OTCQB is a U.S. trading platform operated by the OTC Markets Group and is the leading marketplace of early-stage and developing U.S. and international companies.

To be eligible, companies must be current in their financial reporting, undergo an annual company verification and management certification process, and meet a minimum bid price test.

“Being posted on the OTCQB is a key milestone in our evolution as one of today’s leading providers of psychedelic therapy,” said Ronan Levy, Chairman and Chief Executive Officer of Field Trip Health & Wellness.

“By trading on the OTCQB, we can achieve increased visibility of Field Trip to U.S. investors and improve our overall liquidity as we grow our global shareholder base,” he added.

Field Trip Health & Wellness Ltd. engages in the development and delivery of psychedelic therapies.

Field Trip Health & Wellness Ltd. opened trading at C$0.105.


More From The Market Online
BriaCell Therapeutics Corp

BriaCell to report positive cancer research at medical convention

BriaCell Therapeutics (TSX:BCT) will present positive clinical data of Bria-IMT at the 2024 American Society of Clinical Oncology in Chicago.

Despite cybersecurity breach, Mainstreet Equity stock is a buy

Mainstreet Equity (TSX:MEQ), a highly profitable property manager with almost 18,000 units, suffered a cybersecurity breach on Tuesday.

@ the Bell: TSX gains on latest economic report

Mining stocks led gainers on the TSX, followed by the financial sector, while the telecom market was the biggest decliner.

BC Transit orders 29 zero-emission buses from NFI subsidiary

NFI Group Inc. (TSX:NFI) subsidiary Alexander Dennis Ltd. receives a firm order for 29 zero-emission Enviro500EV buses from BC Transit.